MYRIAD GENETICS, INC.
Net Cash Flow Breakdown
Total Cash from Operations: $181.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $9.4M | 5.2% |
| Business Acquisitions | $799.0K | 0.4% |
| Other Investing | $22.7M | 12.6% |
| Stock Repurchases | $108.9M | 60.1% |
| Working Capital | $5.7M | 3.1% |
| Net Cash Flow | $33.7M | 18.6% |